Cancer drugs that received accelerated approval from the FDA gained regular approval significantly faster if their ...

Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data ...

Penpulimab is approved for multiple indications in China, but this marks the first US approval for the novel monoclonal ...

Waksal, who is not a medical doctor, imported the veterinary drug along with other “unapproved ingredients” from Colombia.

Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

Following a positive readout for its closely watched PD-1xVEGF bispecific ivonescimab, Akeso has won the FDA’s go-ahead for ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...

On March 28, the FDA approved Imfinzi for use in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by single-agent Imfinzi as adjuvant treatment after radical cystectomy, ...

The FDA's move stops short of the outright ban that had been floated for in Kennedy's "Make America Healthy Again" platform ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...